Insights Center

Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.

Featured

Mintz Direct

On our new Mintz Direct page, Mintz thought leaders across industries and practice areas offer timely insights on developments that impact our clients and communities. Visit the Mintz Direct page to hear what our experienced attorneys and professionals are saying about what’s happening now.

Mintz Viewpoints

Use quotation marks to search for an exact phrase (e.g. “class action”)

Published

Showing 11321 - 11328 of 11617 results

The Mintz Class Action Monitoring and Recovery Practice

July 25, 1998| Alert| Viewpoint

Team Resolves Investigation of HSR 2nd Request

Case Study

Licensing Revenue Success for AST in Multi-Prong Program

Case Study

Mintz Preserves 105 out of 107 Challenged Claims

Case Study

Federal Circuit Success For NextGen Healthcare

Case Study

CAFC Victory: PTAB IPR Decision Overturned

Case Study

Successful Defense via Alice Motion in EDTX

Case Study

IPR Victories in Innovators’ Hatch-Waxman Battles

Case Study

News & Press Releases

Mintz Announces New Members

December 20, 2024

Mintz announces the election of eight attorneys to Members, effective January 1, 2025. The newly promoted Members join the ranks of the firm’s growing membership, including six new lateral Members who joined the firm in 2024.

Mintz Advises US Department of Energy LPO on $1.45B Loan Guarantee to Qcells

December 20, 2024

Mintz represented the US Department of Energy (DoE) Loan Programs Office (LPO) in the closing of a $1.45 billion loan guarantee to Hanwha Q Cells Georgia, Inc. (QCells), a leading North American crystalline silicon solar manufacturer.

Dealmaking Dormant No More

December 17, 2024

International Chair of Life Sciences Cheryl Reicin recently participated in a Q&A with Pharmaceutical Executive in which she discusses the ongoing effects of the pandemic on dealmaking trends in the pharmaceutical industry. Cheryl specifically mentions how M&A activity began to rise again in 2024 after slowing in 2023, and that she expects acquisitions to continue picking up in 2025.

View all News and Press Releases